NewsRx

Search our medical news database

Implant Sciences Corp.

U.S. CMS payment code issued for radioactive treatment source

Published in Biotech Law Weekly, October 14th, 2005

Implant Sciences Corp. (IMX, IMX.WS) has received a payment code from the Centers for Medicare & Medicaid Services (CMS) effective October 1, 2005 for its new Ytterbium-169 (Yb-169) brachytherapy source.

This milestone now allows users of this new radioactive source to be reimbursed by Medicare and Medicaid for the treatment of their patients.

With this payment code in place, along with the U.S. Food and Drug Administration (FDA) 510(k) premarket clearance received earlier this year, the company has no more Government regulatory barriers to commercialization. The company currently plans to treat a select number of patients in the last quarter of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook